mouse naive cd4 t cells (R&D Systems)
Structured Review

Mouse Naive Cd4 T Cells, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 32 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse naive cd4 t cells/product/R&D Systems
Average 92 stars, based on 32 article reviews
Images
1) Product Images from "Inhibition of Pyruvate Dehydrogenase Kinase 4 in CD4 + T Cells Ameliorates Intestinal Inflammation"
Article Title: Inhibition of Pyruvate Dehydrogenase Kinase 4 in CD4 + T Cells Ameliorates Intestinal Inflammation
Journal: Cellular and Molecular Gastroenterology and Hepatology
doi: 10.1016/j.jcmgh.2022.09.016
Figure Legend Snippet: PDK4 or p-PDHE1α is enriched in CD4 + T cells from a mouse model of DSS-induced colitis. ( A and B ) WT mice received 2.5% DSS in drinking water for 0, 2, 4, 6, or 8 days. The experiment was repeated twice. ( A ) Representative Western blots of PDK1-4, p-PDHE1α, and β-actin expression in colon tissues (n = 2–3). ( B ) Representative images of immunohistochemistry staining of p-PDHE1α in colon tissues from mice after treatment with DSS for 6 days (n = 3). Scale bar, 100 μm. ( C ) Gating strategy used to examine expression of p-PDHE1α in gut neutrophils, macrophages, dendritic cells, CD8 + T cells, and CD4 + T cells. ( D–G ) p-PDHE1α levels in cells isolated from the colon of mice at day 0 (Ctrl) and day 6 (DSS-6d) of DSS treatment were analyzed by flow cytometry (n = 5, Ctrl; n = 6, DSS-6d). Expression of p-PDHE1α by ( D ) CD45 + (hematopoietic cells) and ( F ) CD45 - (non-hematopoietic cells) in the lamina propria single-cell population isolated from DSS-treated mice. ( E ) CD3 + T cells were further gated into CD3 + CD4 + and CD3 + CD8 + T-cell populations. ( G ) Ly6G + (neutrophils), CD11b + (macrophages), CD11c + (dendritic cells), and CD45 + Ly6G - CD11b - CD11c - cells. The experiment was repeated twice. Mean ± standard error; ∗ P < .05, ∗∗ P < .01 (Student t test).
Techniques Used: Western Blot, Expressing, Immunohistochemistry, Staining, Isolation, Flow Cytometry
Figure Legend Snippet: Augmented expression of p-PDHE1α in lamina propria immune cells from patients with IBD. ( A and B ) Representative IHC staining of PDK4 and p-PDHE1α in inflamed (I) or noninflamed (N) colonic biopsies from patients with CD (n = 13) and UC (n = 11). Scale bar, 100 μm. ( C and D ) Co-immunofluorescence staining of p-PDHE1α ( magenta ) and ( C ) CD4 ( yellow ) or ( D ) CD64 (yellow) in inflamed tissues from patients with IBD (n = 14) and controls (n = 6). Co-staining is indicated by green arrow . Nuclei are stained with DAPI ( cyan ). ( E ) Ratios of p-PDHE1α–positive cells to CD4 + T cells and CD64 + macrophages. Mean ± standard error; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001 (Student t test).
Techniques Used: Expressing, Immunohistochemistry, Immunofluorescence, Staining
Figure Legend Snippet: PDK4 deficiency protects against DSS-induced colitis. C57BL/6J PDK4 KO or WT mice received 2.5% DSS in drinking water for 6 days (n = 6). The experiment was repeated 3 times. ( A ) Weight changes. ( B ) Disease activity scores. ( C ) Histologic scores. ( D ) Representative H&E staining. Scale bars: upper, 500 μm; lower, 100 μm. ( E ) Gross image of the colon. ( F ) Colon length. ( G ) In vivo intestinal permeability test. ( H ) Relative levels of mRNA transcripts encoding Ifng, Il1b, Il6, Il12b, Il17a, and Tnfa in colon tissues (n = 6). ( I ) Gating strategy to identify Th1 (IFN-γ), Th17 (IL17α), and Tregs (Foxp3 + CD25 + ) cells. ( J ) Percentage of helper CD4 + T cells (CD4) among CD3 + T-cell population in the lamina propria was measured by flow cytometry. ( K ) Flow cytometry analysis of percentage of Th1 (IFN-γ), Th17 (IL17α), and Treg (Foxp3 + CD25 + ) cells among gut-infiltrating CD4 + T cells. ( L ) Ex vivo cytokine production (IFN-γ, IL1β, IL6, IL12, IL17, and TNF-α) of colon organ cultures was measured by ELISA (n = 6). Mean ± standard error; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001 (Student t test).
Techniques Used: Activity Assay, Staining, In Vivo, Permeability, Flow Cytometry, Ex Vivo, Enzyme-linked Immunosorbent Assay
Figure Legend Snippet: PDK4 deletion by CD4-Cre reduced intestinal inflammation in mice. ( A–C ) Validation of PDK4 CD4 mouse line. ( A ) Expression of PDK4 protein in kidney, liver, and spleen samples from PDK4 WT PDK4 fl/fl or PDK4 CD4 mice. ( B ) Relative protein expression was normalized to that of HSP90. ( C ) Pdk4 (exon2) mRNA transcript levels in MACS-sorted CD4 + or CD4 - cells, as measured by quantitative PCR. (D–K) PDK4 fl/fl (denoted as WT) and PDK4 CD4 (denoted as KO) mice (n = 6–8/group) received 2.5% DSS in drinking water for 6 days. The experiment was repeated 3 times. ( D ) Weight changes. ( E ) Disease activity scores. ( F ) Histologic scores. ( G ) Representative H&E staining of tissues from PDK4 fl/fl and PDK4 CD4 mice. Scale bars: upper, 500 μm; lower, 100 μm. ( H ) Gross image of the colon. ( I ) Colon length. ( J ) In vivo intestinal permeability test. ( K ) Relative expression of mRNA transcripts encoding Ifng, Il1b, Il6, Il12b, Il17a, and Tnfa in colonic tissues. ( L ) Gating strategy to identify Th1 (IFN-γ), Th17 (IL17α), and Tregs (Foxp3 + CD25 + ) cells (n = 6 mice/group). ( M ) Percentage of helper CD4 + T cells (CD4) among the CD3 + T-cell population in the lamina propria was measured by flow cytometry. ( N ) Flow cytometry analysis of percentage of Th1 (IFN-γ), Th17 (IL17α), and Treg (Foxp3 + CD25 + ) cells among gut-infiltrating CD4 + T cells. ( O ) Ex vivo cytokine production (IFN-γ, IL1β, IL6, IL12, IL17, and TNF-α) of colon organ cultures was measured by ELISA (n = 5). Mean ± standard error; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001 (Student t test).
Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Activity Assay, Staining, In Vivo, Permeability, Flow Cytometry, Ex Vivo, Enzyme-linked Immunosorbent Assay
Figure Legend Snippet: PDK4-deficient T cells delay intestinal homing and induction of colitis after adoptive transfer. Rag1 -/- mice received 4 × 10 5 CD4 + CD45RB hi CD25 - T cells sorted from splenocytes isolated from WT or PDK4 KO mice (n = 9). The experiment was repeated 3 times. ( A ) Weight changes. ( B ) Disease activity scores. ( C ) Histologic scores. ( D ) Representative H&E staining of tissues from PDK4 fl/fl and PDK4 CD4 mice. Scale bars: upper, 500 μm; lower, 100 μm. ( E ) Gross image of the colon. ( F ) Colon length. ( G ) In vivo intestinal permeability test. ( H ) Relative expression of mRNA transcripts encoding Ifng, Il1b, Il6, Il12b, Il17a, and Tnfa in colon tissues (n = 6). ( I ) Gating strategy to identify Th1 (IFN-γ), Th17 (IL17α), and Tregs (Foxp3 + CD25 + ) cells (n = 6 mice/group). ( J ) Percentage of helper CD4 + T cells (CD4) among the CD3 + T-cell population in the lamina propria was measured by flow cytometry. ( K ) Flow cytometry analysis of percentage of Th1 (IFN-γ), Th17 (IL17α), and Treg (Foxp3 + CD25 + ) cells among gut-infiltrating CD4 + T cells. ( L ) Ex vivo cytokine production (IFN-γ, IL1β, IL6, IL12, IL17, and TNF-α) of colon organ cultures was measured by ELISA (n = 6). Mean ± standard error; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001 (Student t test). ( M and N ) Natural Treg-depleted naive CD4 + T cells (CD4 + CD45RB hi CD25 - ) were transferred to Rag1-/- mice. Samples were collected from the spleen and mesenteric lymph nodes and subjected to flow cytometry analysis to investigate whether PDK4 KO T cells show normal survival, proliferation, and tissue-homing capacity in secondary lymphoid organs [( M ) spleen and ( N ) mesenteric lymph nodes] in vivo.
Techniques Used: Adoptive Transfer Assay, Isolation, Activity Assay, Staining, In Vivo, Permeability, Expressing, Flow Cytometry, Ex Vivo, Enzyme-linked Immunosorbent Assay
Figure Legend Snippet: PDK4 differentially regulates expression of genes associated with T-cell activation. ( A and B ) WT naive CD4 + T cells were treated with αCD3 and αCD28 for 0, 1, 2, 4, 8, 24, and 48 hours. The fold changes in protein and mRNA expression of each PDK1-4 isotype were measured by Western blotting and qPCR, respectively. ( C ) Meta-analysis of PDK transcript levels in human WT naive CD4 + T cells after TCR-induced activation based on previously published gene expression data sets (GSE96538). Expression levels were normalized to T = 2 hours. ( D ) WT or PDK4 KO naive CD4 + T cells were activated for 48 hours under Th0 conditions. Scatter plot of Gene Set Enrichment Analysis (GSEA) using a gene set of interest (immune response on C2:KEGG or C2:BIOCARTA pathway database). ( E ) Next-generation sequencing identified 425 differentially expressed genes (DEGs). Volcano plot showing DEGs based on the following cutoff setting ( P value <.05; fold change >1.5). Overall, 210 genes were down-regulated and 215 were up-regulated in KO T cells. DEGs associated with lymphocyte activation (GO:0046649) were labeled. ( F ) GSEA of genes involved in regulation of lymphocyte activation (GO:0051249). ( G ) PDK4 WT or KO naive CD4 + T cells were stimulated for 3 days under Th0 conditions in presence/absence of IL2 (n = 4). T-cell activation makers (CD62L - , CD25 + , CD69 + ) were analyzed by flow cytometry. The experiment was repeated twice. ( H–M ) Naive CD4 + PDK4 WT or KO T cells were activated for 72 hours (n = 2–3). ( H ) Cell size, as assessed by forward scatter (FSC), and ( I ) cell granularity, as assessed by side scatter (SSC). ( J ) Secreted IFN-γ and IL17α were measured in sandwich ELISAs. Viability, proliferation, and apoptosis were evaluated by ( K ) Live/Dead staining, ( L ) CFSE staining, and ( M ) PI/Annexin V staining. This experiment was repeated at least twice. Mean ± standard error, Student t test: ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.
Techniques Used: Expressing, Activation Assay, Western Blot, Next-Generation Sequencing, Labeling, Flow Cytometry, Staining
Figure Legend Snippet: PDK4 mediates metabolic reprograming of activated CD4 + T cells and T-cell differentiation. ( A ) Scatter plot of Gene Set Enrichment Analysis (GSEA) results using a gene set of interest (metabolic process on C2:KEGG or C2:BIOCARTA pathway database). ( B ) Heatmap showing expression of genes associated with glycolytic enzymes and the mTOR signaling pathway. ( C ) GSEA plot showing genes involved in positive regulation of glycolytic processes (Gene set GO:0045821). ( D–F ) WT or PDK4 KO CD4 + T cells were stimulated for 3 days under Th0 conditions. ( D ) Glycolysis stress test assessed using an XF96 analyzer. The experiment was repeated 3 times. ( E ) Basal glycolysis measured in glycolysis stress test. ( F ) Glycolytic capacity was measured in glycolysis stress test. ( G ) Oxygen consumption rate was measured in mitochondrial stress test. ( H–K ) Basal OCR, maximal OCR, reserve capacity OCR, and ATP-linked OCR were calculated on basis of the mitochondrial stress test. ( L ) Ratio of basal OCR to basal ECAR. ( M ) Relative amounts of cytosolic lactate were measured by liquid chromatography-mass spectrometry. ( N ) Frequency of phosphorylated ribosomal protein S6 (p-RPS6) was analyzed by flow cytometry (n = 3). ( O–R ) PDK4 WT or KO naive CD4 + T cells were differentiated for 2 days under ( O ) Th1, ( P ) Th2, ( Q ) Th17, or ( R ) Treg polarizing conditions. Each T-cell subsets were identified by flow cytometry analysis. The experiment was repeated 3 times. Mean ± standard error, Student t test: ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001.
Techniques Used: Cell Differentiation, Expressing, Liquid Chromatography, Mass Spectrometry, Flow Cytometry
Figure Legend Snippet: MAM/SOCE/NFAT pathway is compromised by PDK4 deletion in activated CD4 + T cells. ( A ) GSEA plot of genes involved in the calcium signaling pathway (KEGG). ( B ) Heatmap of DEGs associated with the KEGG calcium signaling pathways. ( C–F ) Cytosolic and mitochondrial calcium were measured using Fura-2 and Rhod-2, respectively (n = 3). This experiment was repeated twice. IP3R-mediated calcium release from ER of naive CD4 + T cells from PDK4 WT or KO mice was induced by ATP ( C and D ) or αCD3 ( E and F ). Later, extracellular calcium (2 mmol/L) was added to induce SOCE. ( G ) Mitochondria-ER colocalization was visualized by co-immunofluorescence staining. CD4 + T cells from PDK4 WT or KO naive were activated for 3 days under Th0 conditions. Co-immunofluorescence staining of ER (PDI, magenta ), mitochondria (VDAC, cyan ), and nuclei (DAPI, blue ). Scale bar, 10 μm. Mander’s coefficient was measured by ImageJ. ( H and I ) Mitochondria-ER colocalization was also visualized by in situ proximity ligation assay ( PLA) ( red dots ). WT or PDK4 KO CD4 + T cells activated by αCD3+αCD28+IL2 for 72 hours. Nuclei were stained with DAPI ( blue ). ( H ) Representative in situ PLA z-stacked images of VDAC1-IP3R, IP3R-GRP75, or GRP75-VDAC1. ( I ) Representative confocal images of in situ PLA ( red dots ) of VDAC1/IP3R. Mean ± standard error; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001 (Mann-Whitney test). ( J ) MAM is enriched in gut-infiltrating CD4 T cells from patients with UC (n = 10) compared with normal controls (n = 5); in situ PLA of VDAC1/IP3R ( red ) co-stained with hCD4 ( green ). Nuclei are stained with DAPI ( blue ). Mean ± standard error, Student t test: ∗∗∗ P < .001. ( K ) Localization of NFATc1 ( green ) upon αCD3/αCD28 stimulation for 0.5 or 12 hours. Nuclei are stained with DAPI ( blue and dashed line ). ( L ) Relative transcription of glycolytic enzymes or transcriptional regulators bearing an NFAT-binding motif. ( M ) Secreted IL2 was measured in sandwich ELISA. Mean ± standard error; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001 (Mann-Whitney test).
Techniques Used: Immunofluorescence, Staining, In Situ, Proximity Ligation Assay, MANN-WHITNEY, Binding Assay, Sandwich ELISA
Figure Legend Snippet: Pharmacologic inhibition of PDK4 inhibits T-cell activation and SOCE in CD4 + T cells and prevents acute/chronic DSS-induced colitis. ( A ) Effects of GM-10395 (0.5, 1, 5, and 10 μmol/L) on dephosphorylation of PDHE1α in activated CD4 + T cells cultured for 6 hours under Th0/IL-2 conditions. The experiment was repeated twice. ( B ) Naive CD4 + T cells were activated under Th0/IL2 conditions and co-treated with GM-10395 (1, 5, 10, 20, and 50 μmol/L) for 72 hours. T-cell activation markers (CD25 + , CD69 + , and CD44 + ) were measured by flow cytometry. Cyclosporin A (CsA; 10 μg/mL) was used as a positive control for T-cell inactivation. The experiment was repeated twice. ( C–F ) Effects of GM-10395 (0.1, 0.3, 1, and 3 μmol/L) on ATP-triggered SOCE. Cytosolic and mitochondrial calcium levels were measured by Fura-2 ( C and D ) and Rhod-2 ( E and F ), respectively. The experiment was repeated twice. Mean ± standard error; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001 (Mann-Whitney test). ( G ) C57BL/6J JmsSlc mice (n = 6) received 4% DSS in drinking water for 9 days. GM-10395 (0.5 or 1 mg per kg) was administered orally. The experiment was repeated twice. ( H ) Body weight. ( I ) Representative images of H&E staining. ( J ) Histologic scores. ( K ) Gross image of the colon. ( L ) Colon length. ( M ) Permeability test results after oral administration of FD4. ( N ) Relative expression of mRNA transcripts encoding Ifng, Il1b, Il6, Il12b, Il17a, and Tnfa in colonic tissues. ( O ) C57BL6J JmsSlc mice (n = 7–8) were treated with 3 cycles of DSS. GM-10395 (1 mg/kg) was administered orally for 1 week, beginning after 3 days of DSS treatment. Mice were anesthetized for colitis examination. ( P ) H&E staining. ( Q ) Histologic scores were evaluated to determine disease severity. ( R ) Disease scores. ( S ) Gross image of the colon. ( T ) Colon length. ( U ) In vivo intestinal permeability. ( V ) Weight changes. Mean ± standard error; ∗ P < .05, ∗∗ P < .01, ∗∗∗ P < .001 (Student t test).
Techniques Used: Inhibition, Activation Assay, De-Phosphorylation Assay, Cell Culture, Flow Cytometry, Positive Control, MANN-WHITNEY, Staining, Permeability, Expressing, In Vivo
